Skip to content

Clinical Study on the Effect of TengFuJiangYa Tablets in Treating Liver Yang Syndrome of hypertension(Grade 1)

Study on Effect substances and mechanisms of Uncaria with Calm the Liver and Suppress Yang by multi-scale principle

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-17011940
Enrollment
Unknown
Registered
2017-07-11
Start date
2017-08-01
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

test group:TengFuJiangYa Tablets, 3 tablets, tid
Control group:Placebo, 3 tablets, tid

Sponsors

Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 18-75 years old; 2. In line with Western diagnostic criteria of hypertension and hyperactivity of liver yang Syndrome Diagnostic Criteria; 3. Clear diagnosis of primary hypertension, blood pressure is still maintained at?140-159/90-99mmHg although having Improved lifestyle or other Non-drug treatments 3 months.Clear diagnosis of primary hypertension, blood pressure is still maintained at?140-159/90-99mmHg although having Improved lifestyleEaten anti hypertensive drugs or other Non-drug treatments 3 months;and Refuse to add another anti hypertensive drug; 4. Meet any of the above two can choose; 5. A clear diagnosis of hypertension must be more than 3 months; 6. Informed consent and signed informed consent

Exclusion criteria

Exclusion criteria: 1. Various secondary hypertension; 2. Nearly three months had received other clinical trials of other drugs; 3. People with severe diabetes or have a heart attack or stroke in half a year; 4. Pregnancy or preparation of pregnancy and breastfeeding women; 5. An allergy to a variety of drugs or allergies; 6. A combination of psychotropic, alcoholic, or psychoactive substance abuse and dependants 7. Combined with the following organ damage or disease: Angina pectoris, heart failure, transient cerebral insufficiency, hypertensive encephalopathy, retinopathy(With or without optic disc edema)Plasma creatinine concentration of 2.0mg/dl or more renal failure, Liver failure, aortic dissection or aortic aneurysm,The symptoms of arterial occlusion are obvious.

Design outcomes

Primary

MeasureTime frame
Blood pressure;The score of TCM syndrome;

Secondary

MeasureTime frame
Vital signs;Routine blood;Liver function;kidney function;Electrocardiogram;The severity and incidence of adverse events;

Countries

China

Contacts

Public ContactLi Yunlun

Shandong University of Traditional Chinese Medicine

li.yunlun@163.com+86 13869102760

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026